Scarica l'app Stockscreener
0.7597
1.09%
-0.0084
Dopo l'orario di chiusura:
.75
-0.0097
-1.28%
Rani Therapeutics Holdings Inc Borsa (RANI) Ultime notizie
RANI Stock Price, Quote & Chart - ChartMill
RANI Stock Price and Chart — NASDAQ:RANI - TradingView
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Javadi Alireza - Moomoo
[Form 4] Rani Therapeutics Holdings, Inc. Insider Trading Activity - Stock Titan
Rani Therapeutics (RANI) grants CBO 805,500 stock options - Stock Titan
Rani Therapeutics (NASDAQ: RANI) CTO awarded 805,500 stock options - Stock Titan
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director IMRAN MIR A - Moomoo
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ausiello Dennis A - Moomoo
Director Abraham Bassan receives 123,600 Rani (RANI) stock options - Stock Titan
Rani Therapeutics (NASDAQ: RANI) director receives stock options on 123,600 shares - Stock Titan
Imran Mir A of Rani Therapeutics (NASDAQ: RANI) receives 123,600 stock options - Stock Titan
Director at Rani Therapeutics (RANI) receives 123,600 stock options as compensation award - Stock Titan
Rani Therapeutics (RANI) director granted 123,600 options at $0.9515 exercise price - Stock Titan
Rani Therapeutics (RANI) director receives 123,600 stock options at $0.9515 strike - Stock Titan
Rani Therapeutics | 8-K: Current report - Moomoo
Rani Therapeutics (RANI) stockholders elect directors and ratify 2026 auditor - Stock Titan
Akkaraju funds lift Rani Therapeutics (RANI) beneficial stake to 9.99% - Stock Titan
Rani Therapeutics to raise $20M in registered direct offering - MSN
Rani Therapeutics | 424B5: Prospectus - Moomoo
Rani Therapeutics Holdings, Inc. Announces Securities Purchase Agreement and Pre-Funded Warrant Offering – SEC 8-K Filing Details - Minichart
Rani Therapeutics (RANI) raises ~$19.99M via Class A shares and pre-funded warrants - Stock Titan
Rani Therapeutics to Raise ~$20M via $1.07 Share Offering and Pre-Funded Warrants - TradingView
Rani Therapeutics (RANI) prices $20M stock and pre-funded warrant sale - Stock Titan
Rani Therapeutics Prices Registered Direct Offering of 12.5 Million Shares - Moomoo
Rani Therapeutics prices $20M direct offering of Class A common stock at market price - Pluang
Rani Therapeutics raises $20 million in direct offering By Investing.com - Investing.com Nigeria
Rani Therapeutics raises $20 million in direct offering - Investing.com
Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules - The Manila Times
Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 - GlobeNewswire
Rani Therapeutics Holdings (RANI) price target decreased by 12.50% to 7.14 - MSN
Maxim Group Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $5 - Moomoo
CCORF Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $5 - Moomoo
Rani Therapeutics Price Target Maintained With a $5.00/Share by Canaccord Genuity - Moomoo
Rani Therapeutics Is Maintained at Buy by Canaccord Genuity - Moomoo
RANI Maintained by Canaccord Genuity -- Price Target Stays at $5 - GuruFocus
Canaccord reiterates Buy on Rani Therapeutics stock, $5 target By Investing.com - Investing.com South Africa
Canaccord reiterates Buy on Rani Therapeutics stock, $5 target - Investing.com
Insiders Enjoy US$582k Return After Buying Rani Therapeutics Holdings Stock - simplywall.st
Lake Street Initiates Rani Therapeutics(RANI.US) With Buy Rating, Announces Target Price $9 - Moomoo
Rani Therapeutics CFO Sanford to depart - MSN
Nasdaq Delisting Risk Looms as Rani Therapeutics Fails to Meet $1 Minimum Bid Price - TipRanks
Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition - The Manila Times
Rani Therapeutics Q1 Net Loss Narrows, Revenue Rises; CFO Svai Sanford to Step Down - Moomoo
RANI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Rani Therapeutics | SCHEDULE 13G/A: Others - Moomoo
Rani Therapeutics reports Q1 EPS (4c), consensus (5c) - TipRanks
Rani Therapeutics Sees Funding Sufficient Into 4Q27 >RANI - Moomoo
Rani Therapeutics CFO to depart, reports Q1 results - Investing.com UK
Rani Therapeutics CFO to depart, reports Q1 results By Investing.com - Investing.com South Africa
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):